Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension | stella

Back to Essential Hypertension trials

Recruiting

Plain-English translation of NCT07930247 on ClinicalTrials.gov ↗ · Source last updated November 2026 · How we translate trials

Trial locations(1 site)

South Korea

HK inno.N, Seoul

Key details

Sponsor

HK inno.N Corporation

Enrollment target

~7,525 participants

Started

May 2026

Primary completion

June 2031

Age range

19 Years and older

Last updated on clinicaltrials.gov in November 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Yong-an Jeong

HK inno.N Corporation

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.